Genocea Biosciences CEO William Clark's 2019 pay slips 19% to $1.1M
Genocea Biosciences reports 2019 executive compensation
By ExecPay News
Published: April 20, 2020
Genocea Biosciences reported fiscal year 2019 executive compensation information on April 20, 2020.
In 2019, three executives at Genocea Biosciences received on average a compensation package of $870K, a 13% increase compared to previous year.
Average pay of disclosed executives at Genocea Biosciences
William Clark, Chief Executive Officer, received $1.1M in total, which decreased by 19% compared to 2018. 50% of Clark's compensation, or $533K, was in salary. Clark also received $242K in non-equity incentive plan, $282K in option awards, as well as $6.4K in other compensation.
Girish Aakalu, Chief Business Officer, received a compensation package of $798K. 48% of the compensation package, or $385K, was in salary.
Thomas Davis, Chief Medical Officer, earned $750K in 2019.
Related executives
You may also like
Source: SEC filing on April 20, 2020.